OncoImmunology
Volume 9, 2020 - Issue 1
Open access
1,909
Views
11
CrossRef citations to date
0
Altmetric
Author's View
Usefulness and robustness of Immunoscore for personalized management of cancer patients
Florence Marliota INSERM, Laboratory of Integrative Cancer Immunology, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, France;d Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France
, Franck Pagèsa INSERM, Laboratory of Integrative Cancer Immunology, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, France;d Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, France
& Jérôme Galona INSERM, Laboratory of Integrative Cancer Immunology, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche DES Cordeliers, Sorbonne Université, Université de Paris, Paris, FranceCorrespondence[email protected]
Article: 1832324
|
Received 28 Sep 2020, Accepted 30 Sep 2020, Published online: 13 Oct 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.